UNIVERSAL DX

UDX is developing a Cancer Platform, a set of minimally-invasive, blood-based solutions for detecting cancer early when treatment-options are more plentiful. Wanna be part of this?... We have built a network of >100 hospitals in the U.S. and across Europe with whom we have recruited >12K samples and work with more than hundred gastrointestinal clinical teams. We are currently running an observational study, USOPTIVAL, for which we are recruiting 1,200 patients at >15 US hospitals... Cancer is too huge of a problem to tackle it alone, so we team up with the best. Our network of world-class R&D partners includes Diagenode -now Hologic (Belgium/U.S.), Polytechnique University of Catalonia (Spain) and Austrian Institute of Technology (Austria). We have built a world-class Scientific Advisory Board from leading oncologist, gastroenterologists, scientists, and business experts from the US and Europe.

Also known as: UDX

Primary location: Cambridge United States